Literature DB >> 8772027

Lymphoepithelioma-like carcinoma of the skin.

S Takayasu1, M Yoshiyama, S Kurata, H Terashi.   

Abstract

Lymphoepithelioma-like carcinoma of the skin is a rare tumor with a microscopic resemblance to lymphoepitheliomatous tumors of the nasopharynx. A 62-year-old woman exhibited such a tumor on the nose together with regional lymph node metastases. Histologically, irregular islands of atypical epithelial cells unconnected to the overlying epidermis were surrounded by or mixed with numerous lymphocytes in the primary tumor. No squamous or glandular differentiation was present. Metastases to the submandibular lymph nodes appeared as glassy squamous cells that resembled trichilemmal keratinization. Staining of the tumor tissues with S-100 protein antibody revealed the presence of numerous short dendritic cells in clusters of epithelial cells. Total resection and adjunctive radiotherapy have led to a 6-year period free of recurrence. This is the second case report of this condition in Japan.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8772027     DOI: 10.1111/j.1346-8138.1996.tb04058.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  3 in total

1.  Lymphoepithelioma-like carcinoma of the skin in a Polish patient.

Authors:  Michał Sobjanek; Magdalena Dobosz; Rafał Pęksa; Małgorzata Sokołowska-Wojdyło; Anna Kowalczyk; Igor Michajłowski; Roman Nowicki
Journal:  Postepy Dermatol Alergol       Date:  2015-02-03       Impact factor: 1.837

2.  Lymphoepithelioma-like carcinoma of the skin treated with wide local excision and chemoradiation therapy: a case report and review of the literature.

Authors:  Theresa M Gille; Edward F Miles; Allen O Mitchell
Journal:  Case Rep Oncol Med       Date:  2012-10-24

3.  Radiotherapy in lymphoepithelioma-like carcinoma of the skin: review of the literature and report of a recurrent and metastatic case.

Authors:  A Mucha-Małecka; K Urbanek; A Ambicka; P Majchrzak; K Małecki
Journal:  Strahlenther Onkol       Date:  2019-09-09       Impact factor: 3.621

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.